AVH Shares AVITA Medical, Inc.
ASX · ASXLast in our picks 2026-10-26 — not in the current list; analysis below is from that screen
Regenerative skin-repair technology and commercial expansion support long-term healthcare growth potential.
Future value: $3.54 (-17.79%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Shares were among healthcare names advancing in recent sector trading.
- ▸Above 50-day MA (+32.52%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (96.5% of range) — strength
- ▾Trading above its price target — limited upside
Is AVH a buy right now?
Trend: AVH is trading above the 50-day average (+30.70%), RSI 60 — neutral momentum, with a 3-month return of +238.58%.
Valuation & quality: AVITA Medical, Inc. trades on forward P/E -13.5, PEG 0.78; fundamentals show net margin -57.0%, revenue growth 17.8% year on year.
Analyst consensus: 4 analysts have a mean 12-month price target of A$3.54 (-17.8% vs the last close; range A$2.20 – A$4.74), consensus rating “buy”.
Our screen: BUY (score 2) — Regenerative skin-repair technology and commercial expansion support long-term healthcare growth potential.
Computed from end-of-day data; not personal advice.
Our track record with AVH
Our simulated $10,000 funds have traded AVH 2 times — 1 of 2 closed trades profitable.
| Fund | Bought | Sold | Return |
|---|---|---|---|
| ASX High-risk | 2026-09-08 @ $3.00 | 2026-09-10 @ $2.78 · AI review sell | -7.33% |
| ASX High-risk | 2026-08-22 @ $2.77 | 2026-09-01 @ $2.79 · Monthly rebalance | +0.72% |
Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -22.50% | +10.90% | -4.10% | +2.60% | +7.50% | +116.30% | +22.60% | +25.70% |
Fundamentals
Analyst price target
Technical signals
About AVITA Medical, Inc.
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
Sector: Healthcare · Industry: Medical Devices · United States · 226 employees · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.